Home / SLC22A17 Knockout Cell Lines

SLC22A17 Knockout Cell Lines

Gene: SLC22A17

Official Full Name: solute carrier family 22 member 17provided by HGNC

Gene Summary: Predicted to enable transmembrane signaling receptor activity. Predicted to be involved in siderophore transport. Located in organelle membrane and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO22681 SLC22A17 Knockout cell line (HCT 116) Human SLC22A17 1:2~1:4 Negative Online Inquiry
KO22682 SLC22A17 Knockout cell line (HEK293) Human SLC22A17 1:3~1:6 Negative Online Inquiry
KO22683 SLC22A17 Knockout cell line (A549) Human SLC22A17 1:3~1:4 Negative Online Inquiry

Background

SLC22A17 Gene Knockout Cell Lines are genetically engineered cellular models designed to lack the functional SLC22A17 gene, which encodes for a solute carrier protein involved in the transport of various substrates across cell membranes. These knockout cell lines facilitate the exploration of the gene's biological role and its implications in various physiological and pathological contexts, such as drug metabolism, cancer biology, and metabolic disorders.

The primary function of the SLC22A17 protein is to mediate the uptake of specific organic compounds, including certain drugs and endogenous metabolites. By utilizing the knockout cell lines, researchers can directly observe the impact of SLC22A17 deficiency on cellular processes, such as drug absorption, distribution, and response to pharmacological agents. The mechanisms underlying altered cell behavior and metabolic activities can be meticulously studied, leading to insights that bridge our understanding between genotype and phenotype.

The scientific importance of these cell lines is underscored by their potential applications in both basic and translational research. They serve as valuable tools for investigating gene function, assessing drug efficacy and toxicity, and developing targeted therapies for conditions influenced by solute carrier activity. Moreover, their ability to mimic specific disease states allows for a deeper understanding of molecular pathways involved in disease etiology.

Compared to traditional models, such as wild-type or non-specific cancer cell lines, SLC22A17 Gene Knockout Cell Lines offer the unique advantage of specificity. This enables researchers to dissect the molecular mechanisms with greater precision and reduces variability related to the presence of confounding gene functions.

For researchers and clinicians looking to advance their work in pharmacology and disease research, these knockout cell lines represent a robust and invaluable resource, providing clarity and specificity in experimental design. Our company specializes in producing high-quality genetic models that empower scientific discovery, backed by a team of experts committed to supporting your research initiatives with reliable, innovative solutions.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.